Pathogenicity, antimicrobial resistance and interpreting evidence

Pathogenicity is a relationship with a host

A pathogen can cause disease in a susceptible host under the relevant conditions. Colonisation, infection and disease are related but different: organisms can occupy a site, interact with or multiply in a host, and cause damage without these descriptions being interchangeable. The host's barriers, immune state, site of entry and exposure can change the outcome.

Virulence concerns the degree or mechanisms of disease-causing effects in a specified context. Adhesion, invasion, toxins and host responses may contribute in particular systems. Detecting a taxon or a candidate virulence gene does not alone establish that it caused a person's illness. Sampling contamination, harmless carriage and other causes remain alternatives requiring appropriate evidence.

Neither Bacteria nor Archaea is a synonym for harmful microbes. Microbial communities have many ecological and host-associated roles. Conversely, a familiar community member can have different effects at a different body site or in a different host condition. The examples here examine principles, without identifying an illness or prescribing treatment.

Drug action depends on both target and access

Different antibacterial agents affect different cellular processes. Examples include peptidoglycan synthesis, translation, nucleic-acid processes and membrane function. A target is a molecular structure or process affected by an agent, not a guarantee that every agent reaches it or that every cell responds identically.

Resistance mechanisms can change access, remove a drug through transport, modify or destroy it, alter a target, or bypass a sensitive pathway. Some reduced susceptibility is intrinsic to a lineage's existing features; other resistance arises through inherited mutation or acquired DNA. A plasmid can carry a relevant gene, but neither plasmid presence nor a wall pattern predicts the response to all antimicrobials.

The resistance belongs to the microbes, not to a human body becoming resistant. Antibiotics act on bacteria rather than treating viral replication through the same bacterial targets. Antimicrobial is a broader term that includes agents directed at other kinds of microbes. Matching a treatment to a clinical situation needs organism-specific, drug-specific and patient-specific evidence beyond this teaching model.

Growth inhibition and survival are distinct

The minimum inhibitory concentration, or MIC, is a defined assay's lowest tested concentration preventing the specified visible-growth outcome. It is conditional on method, medium, time and organism. It is not a direct count of all surviving cells, an exact universal boundary between life and death, or a treatment dose.

The assigned growth table uses unnamed concentration units: at 0 and 1 all three populations A, B and C show growth; at 2 only B does; at 4 and 8 none does. A and C therefore have an MIC of two tested units, while B has four. B shows a higher growth-inhibition threshold in this comparison. No clinical susceptibility breakpoint, actual drug or treatment recommendation is supplied.

In a separate fixed-exposure record, A has surviving counts 1,000, 100, 10 and 1 over model times zero to three. C has 1,000, 500, 250 and 125. The same MIC accompanies different killing patterns. This is consistent with greater tolerance in C under the assigned exposure, rather than a higher MIC. A survival endpoint alone would provide less information than the time series.

Persistence refers to a subpopulation surviving exposure without the higher growth-inhibition threshold defining resistance. A characteristic killing curve can have a fast initial decline and a slower surviving tail. The A/C records do not assign such a two-subpopulation mechanism, so neither is labelled a proved persister population. Tolerance and persistence can have genetic determinants; their distinction from resistance concerns the phenotype measured, not a simple genetic-versus-nongenetic division.

Selection changes a population without purposeful mutation

The selection model starts with nine hundred S cells and one hundred R cells. Their inherited difference already exists. During one assigned exposure, S survival is one percent and R survival is eighty percent. The resulting counts are nine S and eighty R. There are fewer cells overall, but R becomes a much larger fraction of the surviving population.

This is differential survival acting on an existing variant. No cell changes its DNA because it knows a drug is coming, and the model contains no new mutation or horizontal transfer during the step. In reality those processes can introduce variants, while selection, movement and other conditions affect their abundance. An increase in a resistance-associated marker alone cannot determine which mechanism occurred.

Evidence about antimicrobial response should therefore keep organism identity, tested agent, conditions, readout and uncertainty together. A gene result, growth threshold, killing curve and clinical outcome can support different claims. Public-health responses combine infection prevention, appropriate diagnostics and appropriate antimicrobial use; the specific medical decision belongs to an adequately assessed case.

Worked example

Check your understanding

1. What does the growth table establish about A, B and C, and what does it leave open?

   Show reasoning

   Under the assigned assay, A and C have MIC two tested units and B has four. The table does not count survivors, assign clinical susceptibility categories, identify a drug dose or predict treatment success.

2. Why can C survive longer than A without having a higher MIC?

   Show reasoning

   Inhibition of visible growth and the rate of killing are different readouts. C's assigned survival declines more slowly despite the same growth-inhibition threshold. That supports a tolerance distinction in this exposure, without proving a persister subpopulation mechanism.

3. In the selection case, did R become more numerous because its fraction rose from 10% to about 90%?

   Show reasoning

   No. R's count decreased from one hundred to eighty, while S decreased much more strongly. The survivor denominator fell to eighty-nine, so R's fraction rose through differential survival of an existing inherited state.

What to carry forward

Name the phenotype and its assay before explaining resistance, tolerance, pathogenicity or evolutionary change.